United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment

Table 4 Multivariate analysis for patient hospitalization and physician visit frequency at first progression vs baseline

Resource	Beta	Rate	95%CI		P
	estimate	ratio	Lower bound	Upper bound	value
Study physician visit1	0.4346	1.5444	1.1014	2.1656	0.0117
Hospitalizations2	-0.0617	0.9402	0.2648	3.3379	0.9240
Study physician visits2	0.1321	1.1412	0.8330	1.5635	0.4108
Other physician visits2	0.6116	1.8433	1.0961	3.0999	0.0211

¹Generalized estimating equations model (assuming binomial distribution and unstructured covariance structure) while controlling for primary neuroendocrine tumor location, age, Eastern Cooperative Oncology Group status, tumor histology, physician specialty and follow-up time;

²Value denotes statistical significance.